Rigenerand
  • About Us
  • Company
    • 3D-Culture Technologies
    • Cell Factory
    • Cell and Gene Therapy
  • Products
    • VITVO
    • Ask a Quotation
    • Distributors
  • Publications
  • Web & News
  • Contacts

Rigenerand is developing and producing cGMP products for cell-gene therapy together with tailored 3D culture biomedical devices for diagnostic and therapeutical applications

May 30, 2022

Evotec adds cell therapy manufacturing facility with acquisition of Rigenerand

December 1, 2021

GEN News: 3D Bioreactor Shows Promise for Donor Cell Therapies

3D-Culture Technologies
Cell and Gene Therapy
Cell Factory

RIGENERAND Srl


Via Maestri del Lavoro, n. 4
41036 Medolla (MO) Italy
Tel. +39 0535 187.61.72
Fax +39 0535 187.20.53
C.F. / P.IVA (VAT) 03281630362
ORDERS orders@rigenerand.it
PEC rigenerand@legalmail.it

Privacy Policy
Cookie Policy
Customers and Suppliers Policy

Rigenerand is
ISO 9001:2015

certificated by TUV SUD

91_iso9001_rigenerand

Member of

Powered by SGWEB

Publications, Peer-Reviewed Papers and Posters

Candini et al. A Novel 3D In Vitro platform for pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. Scientific Reports 9:7154 (2019)

Candini et al. VITVO: Mimicking In Vivo Complexity By The Innovative 3D Model. Presented at 3D culture, Organoids & Tox screening Europe. 13-14 June 2019. Rotterdam (NL)

Foppiani et al., VITVO: A Novel 3D In Vitro System For Functional Prediction Of Patient Anti-tumor Immune Response To Checkpoint Inhibitors. Presented at The Resarch & Technology Series: Immuno-Oncology. 10 – 11 Oct 2019. London (UK)

Prapa et al., Challenging Gd2-specific Car T Cells Against Primary Patient-derived Glioblastoma Cells. Presented at CAR-TCR Summit Europe. 25-27 Feb 2019. London (UK)

Grisendi et al., Challenging Pancreatic Ductal Adenocarcinoma & Its Stroma by a Combination of Chemo & Gene Therapy: a Pre-Clinical Study. Presented at AACR -Pancreatic Cancer: Advances in Science and Clinical Care. 6-9 Sept 2019. Boston (US)

Casari et al., Targeting Pancreatic Ductal Adenocarcinoma with a Chemo & Gene Therapy Strategy. Presented at PhD Day 2020, Molecular and Regenerative Medicine, UNIMORE. 20 Feb 2020. Modena (IT)

Corallo Diana, Frabetti Stella, Candini Olivia, Gregianin Elisa, Dominici Massimo, Fischer Horst, Aveic Sanja. Emerging Neuroblastoma 3D In Vitro Models for Pre-Clinical Assessments.
Frontiers in Immunology, 26 November 2020
| https://doi.org/10.3389/fimmu.2020.584214

Download VITVO® Book

DOWNLOAD VITVO BOOK


Download Application Notes

#1 Human Primary Glioblastoma Neurospheres Cultured in VITVO® 3D Bioreactor

DOWNLOAD Application Note #1

#2 Anti-Mitochondria Immunohistochemistry On Paraffin-Embedded Human Glioblastoma Neurospheres Cultured in VITVO®

DOWNLOAD Application Note #2

#3 Growth And Imaging Of Neural Stem Cells in VITVO®

DOWNLOAD Application Note #3

#4 In VITVO® Multilayered Culture Using GrowDex-T Hydrogel

DOWNLOAD Application Note #4

#5 Freezing 3D Cell Cultures In VITVO®

DOWNLOAD Application Note #5

#6 In VITVO® Evaluation of The Anticancer Effect of Chemotherapeutics Combination on a 3D Pancreatic Tumor Model

DOWNLOAD Application Note #6

#7 In VITVO® Imaging of 3 D cell culture using In Vivo Imaging System

DOWNLOAD Application Note #7

#8 Identification Of Effective Doses For a Cell-based Therapy Approach In VITVO®

DOWNLOAD Application Note #8

#9 Live Imaging of Anti Cancer Therapy Effect in VITVO®

DOWNLOAD Application Note #9

#10 Dynamic cell culture In VITVO® using the ibidi Pump System

DOWNLOAD Application Note #10

#11 In VITVO® Real Time Monitoring Of 3D Cell Culture

DOWNLOAD Application Note #11

How to become a distributor? Fill out the form below and we will contact you

Become a Distributor
Invio